Profile | GDS5420 / 209635_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 696.18 | 73 |
GSM1296119 | B_lesional_pre-dose | 479.78 | 67 |
GSM1296076 | C_lesional_pre-dose | 516.7 | 69 |
GSM1296092 | D_lesional_pre-dose | 410.09 | 65 |
GSM1296103 | E_lesional_pre-dose | 713.81 | 73 |
GSM1296078 | F_lesional_pre-dose | 498.87 | 69 |
GSM1296107 | G_lesional_pre-dose | 570.93 | 70 |
GSM1296109 | H_lesional_pre-dose | 659.03 | 72 |
GSM1296080 | I_lesional_pre-dose | 212.35 | 54 |
GSM1296090 | J_lesional_pre-dose | 318.22 | 61 |
GSM1296074 | K_lesional_pre-dose | 528.8 | 70 |
GSM1296111 | L_lesional_pre-dose | 541.43 | 69 |
GSM1296099 | M_lesional_pre-dose | 702.04 | 73 |
GSM1296086 | O_lesional_pre-dose | 350.63 | 63 |
GSM1296117 | P_lesional_pre-dose | 678.1 | 73 |
GSM1296113 | Q_lesional_pre-dose | 545.7 | 69 |
GSM1296096 | R_lesional_pre-dose | 742.22 | 74 |
GSM1296105 | S_lesional_pre-dose | 353.99 | 61 |
GSM1296098 | T_lesional_pre-dose | 462.61 | 66 |
GSM1296101 | U_lesional_pre-dose | 655.34 | 72 |
GSM1296121 | V_lesional_pre-dose | 591.57 | 71 |
GSM1296088 | W_lesional_pre-dose | 286.35 | 59 |
GSM1296082 | X_lesional_pre-dose | 341.64 | 62 |
GSM1296115 | Y_lesional_pre-dose | 655.71 | 72 |
GSM1296084 | Z_lesional_pre-dose | 269.67 | 57 |
GSM1296072 | B_lesional_day8 | 378.91 | 63 |
GSM1296069 | L_lesional_day8 | 553.72 | 69 |
GSM1296071 | P_lesional_day8 | 434.25 | 64 |
GSM1296070 | Y_lesional_day8 | 550.39 | 69 |
GSM1296073 | V_lesional_day8 | 668.82 | 73 |
GSM1296034 | A_lesional_day15 | 275.69 | 56 |
GSM1296041 | G_lesional_day15 | 668.28 | 73 |
GSM1296035 | R_lesional_day15 | 731.91 | 74 |
GSM1296038 | U_lesional_day15 | 713.93 | 74 |
GSM1296047 | B_lesional_day15 | 357.59 | 61 |
GSM1296039 | E_lesional_day15 | 616.02 | 72 |
GSM1296042 | H_lesional_day15 | 455.86 | 66 |
GSM1296043 | L_lesional_day15 | 613.48 | 71 |
GSM1296037 | M_lesional_day15 | 458.58 | 66 |
GSM1296046 | P_lesional_day15 | 342.37 | 60 |
GSM1296044 | Q_lesional_day15 | 466.41 | 66 |
GSM1296045 | Y_lesional_day15 | 463.68 | 66 |
GSM1296025 | C_lesional_day15 | 195.95 | 53 |
GSM1296033 | D_lesional_day15 | 231.26 | 55 |
GSM1296027 | I_lesional_day15 | 119.54 | 46 |
GSM1296032 | J_lesional_day15 | 154.53 | 48 |
GSM1296024 | K_lesional_day15 | 250.08 | 57 |
GSM1296031 | W_lesional_day15 | 205.84 | 52 |
GSM1296028 | X_lesional_day15 | 196.78 | 52 |
GSM1296029 | Z_lesional_day15 | 176.96 | 50 |
GSM1296026 | F_lesional_day15 | 413.54 | 65 |
GSM1296030 | O_lesional_day15 | 230.48 | 56 |
GSM1296040 | S_lesional_day15 | 610.32 | 71 |
GSM1296036 | T_lesional_day15 | 537.98 | 68 |
GSM1296048 | V_lesional_day15 | 504.31 | 68 |
GSM1296059 | A_lesional_day43 | 700.98 | 73 |
GSM1296066 | G_lesional_day43 | 586.92 | 70 |
GSM1296060 | R_lesional_day43 | 499.71 | 67 |
GSM1296063 | U_lesional_day43 | 623.14 | 72 |
GSM1296064 | E_lesional_day43 | 841.14 | 77 |
GSM1296067 | H_lesional_day43 | 314.92 | 58 |
GSM1296062 | M_lesional_day43 | 425.89 | 64 |
GSM1296068 | Q_lesional_day43 | 356.53 | 61 |
GSM1296050 | C_lesional_day43 | 275.95 | 58 |
GSM1296057 | D_lesional_day43 | 364.16 | 62 |
GSM1296052 | I_lesional_day43 | 142.97 | 48 |
GSM1296054 | J_lesional_day43 | 179.46 | 50 |
GSM1296049 | K_lesional_day43 | 220.57 | 54 |
GSM1296055 | W_lesional_day43 | 399.21 | 63 |
GSM1296053 | X_lesional_day43 | 133.6 | 46 |
GSM1296058 | Z_lesional_day43 | 527.13 | 68 |
GSM1296051 | F_lesional_day43 | 355.66 | 63 |
GSM1296056 | O_lesional_day43 | 540.42 | 69 |
GSM1296065 | S_lesional_day43 | 562.43 | 69 |
GSM1296061 | T_lesional_day43 | 495.63 | 67 |
GSM1296095 | A_non-lesional_pre-dose | 629.96 | 72 |
GSM1296120 | B_non-lesional_pre-dose | 392.96 | 63 |
GSM1296077 | C_non-lesional_pre-dose | 405.77 | 64 |
GSM1296093 | D_non-lesional_pre-dose | 156.44 | 47 |
GSM1296104 | E_non-lesional_pre-dose | 738.8 | 74 |
GSM1296079 | F_non-lesional_pre-dose | 179.82 | 51 |
GSM1296108 | G_non-lesional_pre-dose | 469.42 | 66 |
GSM1296110 | H_non-lesional_pre-dose | 385.46 | 62 |
GSM1296081 | I_non-lesional_pre-dose | 91.58 | 42 |
GSM1296091 | J_non-lesional_pre-dose | 274.45 | 58 |
GSM1296075 | K_non-lesional_pre-dose | 573.29 | 71 |
GSM1296112 | L_non-lesional_pre-dose | 458.08 | 65 |
GSM1296100 | M_non-lesional_pre-dose | 365.61 | 62 |
GSM1296087 | O_non-lesional_pre-dose | 163.96 | 51 |
GSM1296118 | P_non-lesional_pre-dose | 371.79 | 62 |
GSM1296114 | Q_non-lesional_pre-dose | 399.36 | 63 |
GSM1296097 | R_non-lesional_pre-dose | 649.4 | 72 |
GSM1296106 | S_non-lesional_pre-dose | 515.02 | 68 |
GSM1296102 | U_non-lesional_pre-dose | 361.34 | 61 |
GSM1296122 | V_non-lesional_pre-dose | 384.71 | 63 |
GSM1296089 | W_non-lesional_pre-dose | 153.99 | 47 |
GSM1296083 | X_non-lesional_pre-dose | 157.71 | 49 |
GSM1296116 | Y_non-lesional_pre-dose | 463.34 | 66 |
GSM1296085 | Z_non-lesional_pre-dose | 125.59 | 45 |